Musculoskeletal Transplant Foundation Inc, operating under the name Mtfbiologics, is located in Edison, NJ. The organization was established in 1996. According to its NTEE Classification (E60) the organization is classified as: Health Support, under the broad grouping of Health Care and related organizations. As of 12/2022, Mtfbiologics employed 1,532 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Mtfbiologics is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Mtfbiologics generated $490.9m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 1.7% each year. All expenses for the organization totaled $469.3m during the year ending 12/2022. While expenses have increased by 0.7% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Mtfbiologics has awarded 540 individual grants totaling $15,375,551. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
MTF IS A NONPROFIT ORG. THAT SAVES AND HEALS LIVES BY HONORING DONATED GIFTS AND SERVING PATIENTS, WE COLLABORATE WITH THE MEDICAL, SCIENTIFIC, AS WELL AS ORGAN AND TISSUE DONATION COMMUNITIES. CONTINUED ON SCHEDULE O.
Describe the Organization's Program Activity:
MTF IS A GLOBAL NONPROFIT ORGANIZATION THAT SAVES AND HEALS LIVES BY HONORING DONATED GIFTS AND SERVING PATIENTS, WE COLLABORATE WITH THE MEDICAL, SCIENTIFIC, AS WELL AS ORGAN AND TISSUE DONATION COMMUNITIES. OUR GOAL IS SIMPLE-DO WHAT'S RIGHT FOR PATIENTS, SURGEONS, TISSUE DONORS, AND THEIR FAMILIES THROUGH OUR GUIDING PRINCIPLES: - WE TRANSFORM BY PROVIDING SAFE, HIGH-QUALITY GRAFTS FROM DONATED HUMAN TISSUES THAT ARE USED IN A GROWING ARRAY OF CLINICAL FIELDS. - WE COLLABORATE BY FORGING RELATIONSHIPS WITH EXPERTS IN TISSUE AND ORGAN RECOVERY, AS WELL AS LEADING PHYSICIANS AND SCIENTISTS, TO ACCELERATE INNOVATION AND ENSURE THE BEST POSSIBLE EXPERIENCES AND OUTCOMES FOR PATIENTS. - WE INNOVATE BY ADVANCING THE SCIENCE OF TRANSPLANTATION BY SUPPORTING RESEARCH WITHIN OUR OWN ORGANIZATION AND AMONG CLINICIANS AND RESEARCHERS WORLDWIDE. - WE GIVE BACK BY REINVESTING IN RESEARCH TO POSITIVELY AFFECT LIVES ACROSS THE GLOBE. SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 160,000 DONORS. IN 2022, MTF RECOVERED TISSUE FROM OVER 6,000 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 5,200 DONORS FOR USE IN BURN, GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 1,000 BIRTH TISSUE DONORS FOR USE PREDOMINANTLY IN WOUND CARE APPLICATIONS AND OVER 900 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED APPROXIMATELY 465,000 UNITS OF ALLOGRAFT TISSUE DURING 2022. MTF IS FOCUSED ON SAVING AND HEALING LIVES AND CONTINUES TO DEVELOP AND INNOVATE HUMAN TISSUE SOLUTIONS TO SOLVE CLINICAL PROBLEMS. MTF HAS ALSO CONTINUED ITS EFFORTS TO PROVIDE RESEARCH TISSUE AND GRANT FUNDING FOR RESEARCH AND DEVELOPMENT PERFORMED BY ACADEMIC CENTERS AND ENTREPRENEURS ALIKE. IN 2022 MTF CONTINUED TO PURSUE ITS MISSION, AND MADE TISSUE FORMS AVAILABLE IN THE ORTHOPEDIC, PLASTIC AND RECONSTRUCTIVE SURGERY, AND WOUND CARE MARKETS THROUGH BOTH INTERNAL AND EXTERNAL DISTRIBUTION RELATIONSHIPS. MTF ORTHOPEDICS LAUNCHED MULTIPLE NEW TISSUE FORMS IN 2022 THAT POSITIONED THE FOUNDATION AND OUR PARTNERS TO HELP MANY MORE PATIENTS IN THE YEARS TO COME. MTF ALSO INITIATED PROCESS EFFICIENCIES THAT WILL MAXIMIZE THE GIFT OF DONATION AND WILL PROVIDE MORE OPPORTUNITIES TO SURGEONS TO ELEVATE THE CONTINUUM OF CARE. IN THE PLASTIC AND RECONSTRUCTIVE SURGERY FRANCHISE, MTF CONTINUED TO TAKE ADVANTAGE OF OPPORTUNITIES IN BUYING GROUP CONTRACTS. CONTINUED FOCUS WAS PLACED ON PROCESSING EFFICIENCIES AND DONOR RECOVERY METHODS TO MAXIMIZE THE GIFT OF DONATION. MTF CONTINUED TO BOLSTER ITS INTER-INDUSTRY PARTNERSHIPS, INCREASING THE AVAILABILITY OF DONATED HUMAN TISSUE, AND THE ABILITY TO BRING HUMAN TISSUE ALLOGRAFTS TO SURGEONS AND PATIENTS. MTF'S WOUND CARE CONTINUED GROWING THROUGHOUT 2022, EXPANDING ITS PRESENCE IN THE SPACE VIA REPRESENTATION AND PROCESSING CAPABILITY. MTF GENERATED MORE CLINICAL AND HEALTH CARE ECONOMIC DATA TO FURTHER THE EXPANSION IN WOUND CARE AND PLASTIC AND RECONSTRUCTIVE SURGERY PROCEDURES, FURTHER ILLUSTRATING THE SAFETY AND VALUE OF ITS TISSUE FORMS. MTF'S MISSION IS TO SAVE AND HEAL LIVES BY HONORING THE DONATED GIFT, SERVING PATIENTS AND ADVANCING SCIENCE. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Joseph A Yaccarino President/ce | Officer | 60 | $804,340 |
Michael J Kawas Treasurer/cf | Officer | 60 | $637,326 |
Thomas C Shaffer Exec VP Sale | Officer | 60 | $563,535 |
Sarah Brusch Surgical Con | 50 | $524,899 | |
Jodie Crabil Surgical Con | 50 | $524,051 | |
Floyd Vaughan Surgical Con | 50 | $494,911 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Conmed Linvatec Tissue Promo | 12/30/22 | $31,675,606 |
Depuy Synthes Tissue Promo | 12/30/22 | $25,388,760 |
Donor Network Of Arizona Recovry Partner | 12/30/22 | $6,686,695 |
Centurion Therapeutics | 12/30/22 | $5,842,151 |
Orthofix Spinal Implants Tissue Promo | 12/30/22 | $56,241,744 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $968,850 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $968,850 |
Total Program Service Revenue | $466,009,432 |
Investment income | $211,652 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $126,656 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $16,412,750 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | -$90,115 |
Miscellaneous Revenue | $0 |
Total Revenue | $490,881,944 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,243,651 |
Grants and other assistance to domestic individuals. | $9,675 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $5,184,233 |
Compensation of current officers, directors, key employees. | $1,728,078 |
Compensation to disqualified persons | $468,082 |
Other salaries and wages | $104,328,688 |
Pension plan accruals and contributions | $4,937,851 |
Other employee benefits | $17,825,703 |
Payroll taxes | $7,047,831 |
Fees for services: Management | $0 |
Fees for services: Legal | $1,087,149 |
Fees for services: Accounting | $431,472 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $896,689 |
Advertising and promotion | $1,904,129 |
Office expenses | $1,044,936 |
Information technology | $832,291 |
Royalties | $3,552,395 |
Occupancy | $13,535,467 |
Travel | $2,954,598 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $4,116,816 |
Interest | $500,714 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $4,214,017 |
Insurance | $1,314,789 |
All other expenses | $5,413,621 |
Total functional expenses | $469,345,667 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $42,675,428 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $68,262,429 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $110,701,962 |
Prepaid expenses and deferred charges | $2,204,656 |
Net Land, buildings, and equipment | $35,802,690 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $3,962,500 |
Other assets | $60,474,961 |
Total assets | $324,084,626 |
Accounts payable and accrued expenses | $66,409,619 |
Grants payable | $3,126,341 |
Deferred revenue | $92,442,472 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $12,400,000 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $45,568,187 |
Total liabilities | $219,946,619 |
Net assets without donor restrictions | $104,138,007 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $324,084,626 |
Over the last fiscal year, Musculoskeletal Transplant Foundation Inc has awarded $1,243,651 in support to 53 organizations.
Grant Recipient | Amount |
---|---|
CASE WESTERN RESERVE UNIVERSITY PURPOSE: RESIDENT EDUCATION | $7,000 |
CASE WESTERN RESERVE UNIVERSITY PURPOSE: SCIENTIFIC RESEARCH | $24,972 |
CEDARS-SINAI MEDICAL CENTER PURPOSE: RESIDENT EDUCATION | $10,000 |
CEDARS-SINAI MEDICAL CENTER PURPOSE: SCIENTIFIC RESEARCH | $50,000 |
CLEMSON UNIVERSITY RESEARCH FOUNDAT PURPOSE: SCIENTIFIC RESEARCH | $150,000 |
CLEVELAND CLINIC FOUNDATION PURPOSE: RESIDENT EDUCATION | $10,000 |